<DOC>
	<DOCNO>NCT03014323</DOCNO>
	<brief_summary>Investigators test hypothesis chronic restoration vagal nerve activity central acetylcholinesterase inhibitor improve insulin sensitivity reduces adipose tissue oxidation obese African American Women compare white woman .</brief_summary>
	<brief_title>Racial Differences Vagal Control Glucose Homeostasis , Chronic Study</brief_title>
	<detailed_description>Investigators test hypothesis chronic restoration parasympathetic nervous system ( PNS ) activity central acetylcholinesterase inhibitor improve insulin sensitivity reduces adipose tissue oxidation obese African American woman ( AAW ) compare white woman ( WW ) . A cross-over study perform matched cohort AAW white woman subject chronic central acetylcholinesterase inhibition galantamine versus placebo , give orally 4-week period . Insulin sensitivity measure use gold standard hyperinsulinemic-euglycemic clamp . Adipose tissue obtain subcutaneous fat biopsy F2-isoprostanes quantify .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<criteria>Inclusion Criteria Female African American white ( race selfdefined , subject report parent race include ) 1860 year old BMI 3045 Kg/m2 Not pregnant breastfeed Exclusion Criteria Pregnant breastfeed Diabetes diagnosis ( defined American Diabetes Association ( ADA ) criterion ) 38 Cardiovascular disease myocardial infarction within 6 month prior enrollment , presence angina pectoris , significant arrhythmia , congestive heart failure ( LV hypertrophy acceptable ) , deep vein thrombosis , pulmonary embolism , mitral valve stenosis , aortic stenosis , hypertrophic cardiomyopathy . Arrhythmia ( first , second , thirddegree AV block ) Significant weight change &gt; 5 % past 3 month Impaired hepatic function ( AST and/or ALT &gt; 1.5X upper limit normal range ) Impaired renal function ( eGFR &lt; 60ml/min ) Users strong inhibitor CYP3A4 CYP2D6 Users acetylcholinesterase inhibitor pyridostigmine bethanechol History alcohol drug abuse Mental condition render subject unable understand nature , scope , possible consequence study Inability comply protocol , e.g. , uncooperative attitude , inability return followup visit , unlikelihood complete study Steroid use within 6 week prior study entry Any underlying acute disease require regular medication could possibly pose threat subject make implementation protocol interpretation study result difficult Discretion investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>insulin sensitivity</keyword>
	<keyword>African American</keyword>
	<keyword>obese</keyword>
</DOC>